Who owns the RESPIBIOME trademark?

The RESPIBIOME trademark is owned by Lallemand Pharma AG.

What class is the RESPIBIOME trademark registered in?

The RESPIBIOME trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for RESPIBIOME?

The USPTO serial number for RESPIBIOME is 79254543.

What is the registration number for RESPIBIOME?

RESPIBIOME is registered under USPTO registration number 5876843.

Sealvo

Home Search: RESPIBIOMERESPIBIOME #79254543

Back

Updated Oct 20, 2026·41 searches this week

View on USPTO TSDR Find similar marks

RES

USPTO Trademark Record

ABANDONED

RESPIBIOME

SN 79254543·Reg 5876843·Filed Feb 15, 2019

Owner Lallemand Pharma AG

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

RESPIBIOME (Serial No. 79254543), Registration No. 5876843, is a abandoned US trademark filed on Feb 15, 2019 by Lallemand Pharma AG. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

RESPIBIOME (Reg. #5876843) is an abandoned US trademark that was filed in 2019 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 15, 2019

SERIAL

79254543

REG#

5876843

REGISTERED

Oct 08, 2019

Filing Information

StatusABANDONED

Filing DateFeb 15, 2019

Serial Number79254543

Registration No.5876843

Registration DateOct 08, 2019

Status DateApr 24, 2026

Published for OppositionJul 23, 2019

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

26 events

CANCELLED SECTION 71

Apr 24, 2026

CANCELLED SECTION 71

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Oct 08, 2024

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

FINAL DECISION TRANSACTION PROCESSED BY IB

Feb 21, 2020

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Feb 04, 2020

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Feb 04, 2020

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jan 08, 2020

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Oct 08, 2019

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Jul 23, 2019

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 23, 2019

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 03, 2019

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

REFUSAL PROCESSED BY IB

Jun 08, 2019

REFUSAL PROCESSED BY IB

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 08, 2019

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 07, 2019

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 07, 2019

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 07, 2019

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY MPU

May 21, 2019

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

May 21, 2019

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Apr 28, 2019

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Apr 27, 2019

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Apr 26, 2019

ASSIGNED TO EXAMINER

NEW REPRESENTATIVE AT IB RECEIVED

Apr 19, 2019

NEW REPRESENTATIVE AT IB RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Apr 10, 2019

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Apr 10, 2019

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

APPLICATION FILING RECEIPT MAILED

Mar 29, 2019

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 25, 2019

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Mar 21, 2019

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks by Lallemand Pharma AG

Additional USPTO filings from the same owner.

LSE

L'SEA

79252376

Lallemand Pharma AG

ABANDONED

Other Marks by Patrick J. Concannon

Additional USPTO filings handled by the same attorney of record.

WER

WE'RE BOCK

98550163

90799608

SPAGNA

73049022

REGISTERED

PRO

PROVANCE

78555663

REGISTERED

RESPIBIOME

Run a conflict check

Other Marks by Lallemand Pharma AG

Other Marks by Patrick J. Concannon

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company